tiprankstipranks
Trending News
More News >
Heidelberg Pharma AG (DE:HPHA)
XETRA:HPHA
Germany Market

Heidelberg Pharma AG (HPHA) Financial Statements

Compare
0 Followers

Heidelberg Pharma AG Financial Overview

Heidelberg Pharma AG's market cap is currently €150.52M. The company's EPS TTM is €-0.446; its P/E ratio is ―; Heidelberg Pharma AG is scheduled to report earnings on July 10, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 6.85M€ 9.86M€ 18.51M€ 1.75M€ 8.49M
Gross Profit€ 4.20M€ 6.61M€ 13.83M€ -2.96M€ 2.89M
Operating Income€ -24.56M€ -21.21M€ -18.33M€ -25.63M€ -18.56M
EBITDA€ -18.37M€ -18.71M€ -16.19M€ -24.83M€ -17.55M
Net Income€ -19.38M€ -20.35M€ -19.70M€ -26.63M€ -18.37M
Balance Sheet
Cash & Short-Term Investments€ 29.42M€ 43.44M€ 81.33M€ 6.14M€ 4.98M
Total Assets€ 60.72M€ 70.35M€ 100.58M€ 21.73M€ 19.61M
Total Debt€ 21.97M€ 5.83M€ 15.98M€ 10.63M€ 202.68K
Net Debt€ -7.45M€ -37.61M€ -65.35M€ 4.49M€ -4.78M
Total Liabilities€ 29.85M€ 21.01M€ 33.94M€ 15.03M€ 6.73M
Stockholders' Equity€ 30.87M€ 49.34M€ 66.64M€ 6.70M€ 12.88M
Cash Flow
Free Cash Flow€ -30.04M€ -34.63M€ -9.48M€ -28.00M€ -19.33M
Operating Cash Flow€ -29.59M€ -33.67M€ -8.86M€ -26.61M€ -17.89M
Investing Cash Flow€ -449.13K€ 5.85M€ -597.57K€ -1.40M€ -1.29M
Financing Cash Flow€ 16.08M€ -10.05M€ 84.00M€ 29.17M€ 14.29M
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History

Heidelberg Pharma AG Debt to Assets

Heidelberg Pharma AG Cash Flow

Heidelberg Pharma AG Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis